When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
6.5 Nature and Contents of Container
Removal of
1. Name of the medicinal product
Change name to: Andrews Liver Salts Effervescent Powder
6.4 Special Precautions for Storage
Amend wording as follows: Keep the container tightly closed.
Include statement: Not all pack sizes may be marketed.
10. Date of revision of text
April 2007